Trademarks
INTERCEPT
- Serial number
- 99073125
- Registration number
- 8310048
- Filed
- 2025-03-07
- Registered
- 2026-06-23
- Status
- Registered (USPTO status code 700, 2026-06-23; as of the dataset)
- Classes
- 005
- Elsewhere
- USPTO TSDR record (current status) ↗
- Source
- TRTDXFAP, file of 2026-06-24
Goods and services
Blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes; pathogen inactivated blood for medical purposes; pathogen inactivated blood products, namely, platelets, plasma, red blood cells, cryoprecipitated plasma and fibrinogen complex for medical purposes; pathogen reduced blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes.
Owners
| Owner | Role | Entity | Place | Also on furp.org | Source |
|---|---|---|---|---|---|
| Cerus Corporation | Original applicant, Owner at publication, Original registrant | Corporation | Concord, CA | CERUS CORPORATION Federal lobbying client EXACT high confidence: identical full name and state | TRTDXFAP, file of 2026-06-24 |
Assignment history
No recorded assignments on file for this mark.
USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.